✦ LIBER ✦

Phase II Trial of High-Dose Rituximab with Thiotepa/Busulfan/Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma

✍ Scribed by Chen, Yi-Bin; Batchelor, Tracy; Hochberg, Ephraim; Brezina, Mark; Coughlin, Erin; Jones, SooAe; Del Rio, Candice; Duong, Amanda; Ballen, Karen; Barnes, Jeffrey; Chi, Andrew; Driscoll, Jessica; Hochberg, Fred; LaCasce, Ann; McAfee, Steven L.; Nayak, Lakshmi; Armand, Philippe

Book ID: 122764761
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 119 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous Stem Cell Transplantation wit

Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma

✍ Gregory M. Cote; Ephraim P. Hochberg; Alona Muzikansky; Fred H. Hochberg; Jan Dr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Phase II Trial of Busulfan-Based Tandem

Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma

✍ Chen, Yi-Bin; Li, Shuli; Del Rio, Candice; Driscoll, Jessica; Sadrzadeh, Hossein 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB

A Phase I Trial of High-Dose Clofarabine

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

✍ Shivani Srivastava; David Jones; Lisa L. Wood; Jennifer E. Schwartz; Robert P. N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Feasibility and Efficacy of High-Dose Me

Feasibility and Efficacy of High-Dose Melphalan, Cyclophosphamide, Etoposide, and Dexamethasone (LEED) Chemotherapy with or without Rituximab Followed by Autologous Stem Cell Transplantation for Aggressive and Relapsed Non-Hodgkin’s Lymphoma

✍ Li-na Han; Jin Zhou; Takayuki Hirose; Yosuke Imai; Takuro Ishiguro; Takaaki Chou 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 137 KB

High-dose chemotherapy with autologous s

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

✍ Colombat, Ph; Lemevel, A; Bertrand, P; Delwail, V; Rachieru, P; Brion, A; Bertho 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

79: Pegfilgrastim (P) Appears to be Equi

79: Pegfilgrastim (P) Appears to be Equivalent to Multiple Daily Doses of Filgrastim (F) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin's Lymphoma: Results of a Randomized Phase II Trial

✍ R. Rifkin; R. Beveridge; G. Spitzer; G. Orloff; R. Mandanas; D. McGaughey; F. Zh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB